Corrigendum

July 23, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Corrigendum to the Consolidated Cash Flow Statement for the year ended March 31, 2026 With reference to the captioned subject and further to our announcement regarding the Audited Financial Results for the quarter and year ended March 31, 2026 dated May 22, 2026; we, M/s Zota Health Care Limited (the “Company”) wish to inform you that there were certain inadvertent typographical errors in the Consolidated Cash Flow Statement, the said figures were identified post submission of the Financial Results for the quarter and year ended March 31, 2026. In light of above, corrigendum to the Consolidated Cash Flow Statement for the year ended March 31, 2026 is enclosed as per (Annexure-1) for your kind perusal. This corrigendum is being issued to rectify the inadvertent error and should be read in conjunction with the Audited Financial Results for the quarter and year ended March 31, 2026 already submitted to the Stock Exchange. This corrigendum is limited to the figures stated above and does not have any impact on the Standalone and Consolidated Audited Statement of Assets and Liabilities, the Audited Standalone & Consolidated Financial Results for the quarter and year ended 31st March, 2026 and the Standalone Cash Flow Statement for the year ended 31st March, 2026. Corrigendum to Audited Financial Results for the quarter and year ended March 31, 2026 shall also be available on the website of the Company at www.zotahealthcare.com and stock exchange i.e. National Stock Exchange of India Limited at www.nseindia.com. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary and Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 (Annexure-1: Corrigendum to the Consolidated Cash Flow Statement for the year ended March 31, 2026) (₹ in lakhs) Particulars Originally Submitted Rectified Figure For the year ended For the year ended March 31, 2026 March 31, 2026 A CASH FLOW FROM OPERATING ACTIVITIES Interest Income 889.98 (632.00) Operating Profit before Working Capital 1397.99 1655.97 Changes Cash Generated from Operations (7295.99) (7038.01) Net Cash Flow from/ (Used in) Operating (8442.54) (8184.55) Activities B CASH FLOW FROM INVESTING ACTIVITIES Acquisition of property, plant and equipment, (11293.15) (12643.00) capital work-in progress and intangible assets Interest Received 889.98 632.00 Net Cash Flow (Used in) Investing Activities (31356.34) (32964.17) C CASH FLOW FROM FINANCING ACTIVITIES Principal payment of lease liability (5546.09) (4196.24) Net Cash Flow from / (Used in) Financing 48994.29 50344.13 Activities